COMBINED MODALITY THERAPY FOR 1ST RECURRENCE OF BREAST-CANCER - A SOUTHWEST ONCOLOGY GROUP-STUDY

被引：0
作者：
HOOGSTRATEN, B
GADELMAWLA, N
MALONEY, TR
FLETCHER, WS
VAUGHN, CB
TRANUM, BL
ATHENS, JW
COSTANZI, JJ
FOULKES, M
机构：
[1] BETHESDA HOSP INC,CINCINNATI,OH
[2] NATL CANC INST,CAIRO,EGYPT
[3] UNIV SO CALIF,SCH MED,LOS ANGELES,CA 90033
[4] UNIV OREGON,HLTH SCI CTR,EUGENE,OR 97403
[5] PROVIDENCE HOSP,SOUTHFIELD,MI 48037
[6] UNIV ARKANSAS MED SCI,LITTLE ROCK,AR 72205
[7] UNIV UTAH,MED CTR,SALT LAKE CITY,UT 84112
[8] UNIV TEXAS,MED BRANCH,GALVESTON,TX 77550
来源：
CANCER | 1984年 / 54卷 / 10期
关键词：
D O I：
10.1002/1097-0142(19841115)54:10<2248::AID-CNCR2820541031>3.0.CO;2-D
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2248 / 2256
页数：9
相关论文
共 50 条
  • [41] METASTATIC SPLENOMEGALY AS THE 1ST MANIFESTATION OF BREAST-CANCER
    MARTI, JB
    FERRER, JV
    BARBER, MTC
    SEMPERE, FV
    MEDICINA CLINICA, 1992, 99 (03): : 119 - 119
  • [42] BREAST-CANCER PROGNOSIS AND DETECTION OF THE 1ST SYMPTOM
    COHEN, P
    BREAST CANCER RESEARCH AND TREATMENT, 1983, 3 (03) : 311 - 311
  • [43] SHORT-TERM CHEMOTHERAPY OF POOR-PROGNOSIS METASTATIC BREAST-CANCER WITH 3 NON-CROSS RESISTANT CHEMOTHERAPY REGIMENS - A SOUTHWEST ONCOLOGY GROUP-STUDY
    AHMANN, FR
    PUGH, R
    CANCER, 1987, 59 (02) : 239 - 244
  • [44] UNEXPECTED TOXICITY OF COMBINED MODALITY THERAPY FOR SMALL CELL-CARCINOMA OF THE LUNG - SOUTHWEST-ONCOLOGY-GROUP STUDY
    LIVINGSTON, RB
    MIRA, J
    HAAS, C
    HEILBRUN, L
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1979, 5 (09): : 1637 - 1641
  • [45] DOXORUBICIN AND CISPLATIN THERAPY IN CHILDREN WITH NEURO-BLASTOMA RESISTANT TO CONVENTIONAL THERAPY - A SOUTHWEST ONCOLOGY GROUP-STUDY
    NITSCHKE, R
    STARLING, K
    LUI, VKS
    PULLEN, J
    CANCER TREATMENT REPORTS, 1981, 65 (11-1): : 1105 - 1108
  • [46] COMBINATION CHEMOTHERAPY (CMFVP) VERSUS L-PHENYLALANINE MUSTARD (L-PAM) FOR OPERABLE BREAST-CANCER WITH POSITIVE AXILLARY NODES - A SOUTHWEST ONCOLOGY GROUP-STUDY
    GLUCKSBERG, H
    RIVKIN, SE
    RASMUSSEN, S
    TRANUM, B
    GADELMAWLA, N
    COSTANZI, J
    HOOGSTRATEN, B
    ATHENS, J
    MALONEY, T
    MCCRACKEN, J
    VAUGHN, C
    CANCER, 1982, 50 (03) : 423 - 434
  • [47] ALTERNATING WEEKLY DOXORUBICIN AND 5-FLUOROURACIL LEUCOVORIN FOLLOWED BY WEEKLY DOXORUBICIN AND DAILY CYCLOPHOSPHAMIDE IN STAGE-IV BREAST-CANCER - A SOUTHWEST ONCOLOGY GROUP-STUDY
    ELLIS, GK
    GREEN, S
    SCHULMAN, S
    COLTMAN, CA
    HYNES, HE
    RIVKIN, S
    LIVINGSTON, RB
    CANCER, 1991, 68 (05) : 934 - 939
  • [48] ADJUVANT THERAPY IN LARGE BOWEL ADENOCARCINOMA - LONG-TERM RESULTS OF A SOUTHWEST ONCOLOGY GROUP-STUDY
    PANETTIERE, FJ
    GOODMAN, PJ
    COSTANZI, JJ
    CRUZ, AB
    VAITKEVICIUS, VK
    MCCRACKEN, JD
    BROWNLEE, RW
    LAUFMAN, L
    STEPHENS, RL
    BONNET, J
    BOTTOMLEY, R
    RIVKIN, S
    FLETCHER, W
    OISHI, N
    CHEN, TT
    JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (06) : 947 - 954
  • [49] MINIMAL SINGLE-AGENT ACTIVITY OF MAYTANSINE IN REFRACTORY BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    NEIDHART, JA
    LAUFMAN, LR
    VAUGHN, C
    MCCRACKEN, JD
    CANCER TREATMENT REPORTS, 1980, 64 (4-5): : 675 - 677
  • [50] THE PRESENCE OF TUMOR-CELLS IN BONE-MARROW AT THE TIME OF 1ST RECURRENCE OF BREAST-CANCER
    KAMBY, C
    GULDHAMMER, B
    VEJBORG, I
    ROSSING, N
    DIRKSEN, H
    DAUGAARD, S
    MOURIDSEN, HT
    CANCER, 1987, 60 (06) : 1306 - 1312
12345